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ARTICLE
Dendritic polyglycerol nanoparticles show charge dependent bio-distribution
in early human placental explants and reduce hCG secretion
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Barbara Obermayer-Pietschc, Denise Hochd, Karin Kornmuellere and Rainer Haagb
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Biochemistry-Organic Chemistry, Freie Universit€at Berlin, Berlin, Germany; cDivision of Endocrinology and Diabetology, Medical
University of Graz, Graz, Austria; dDepartment of Obstetrics and Gynecology, Medical University of Graz, Graz, Austria; eInstitute of
Biophysics, Medical University of Graz, Graz, Austria
ABSTRACT
A thorough understanding of nanoparticle bio-distribution at the feto-maternal interface will be
a prerequisite for their diagnostic or therapeutic application in women of childbearing age and
for teratologic risk assessment. Therefore, the tissue interaction of biocompatible dendritic poly-
glycerol nanoparticles (dPG-NPs) with first- trimester human placental explants were analyzed
and compared to less sophisticated trophoblast-cell based models. First-trimester human placen-
tal explants, BeWo cells and primary trophoblast cells from human term placenta were exposed
to fluorescence labeled, 5 nm dPG-NPs, with differently charged surfaces, at concentrations of
1 mM and 10nM, for 6 and 24h. Accumulation of dPGs was visualized by fluorescence micros-
copy. To assess the impact of dPG-NP on trophoblast integrity and endocrine function, LDH, and
hCG releases were measured. A dose- and charge-dependent accumulation of dPG-NPs was
observed at the early placental barrier and in cell lines, with positive dPG-NP-surface causing
deposits even in the mesenchymal core of the placental villi. No signs of plasma membrane
damage could be detected. After 24 h we observed a significant reduction of hCG secretion in
placental explants, without significant changes in trophoblast apoptosis, at low concentrations of
charged dPG-NPs. In conclusion, dPG-NP’s surface charge substantially influences their bio-distri-
bution at the feto-maternal interface, with positive charge facilitating trans-trophoblast passage,
and in contrast to more artificial models, the first-trimester placental explant culture model
reveals potentially hazardous influences of charged dPG-NPs on early placental physiology.
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Nanomaterial interaction with human placenta is
insufficiently understood. This impedes the develop-
ment of beneficial nanomaterial-based diagnostics
and treatments for pregnant women (Keelan et al.
2015; Harris 2016; Muoth et al. 2016) as well as
embryonic risk assessment of human first trimester
exposures to nanomaterials. Models commonly used
to analyze placental nanomaterial kinetics and tis-
sue compatibility either focused on late human ges-
tation only, like the human placental perfusion
model (Grafmueller et al. 2015), or primarily studied
human trophoblast-tumor cell interactions with
nanomaterials, e.g. based on the BeWo-b30
choriocarcinoma models (Cartwright et al. 2012; Ali
et al. 2013; Correia Carreira et al. 2015a; Poulsen
et al. 2015). Animal models for the investigation of
nanomaterial exposures in early gestation are pre-
dominantly based on rats and mice. The results,
however, are difficult to translate to the human
situation since these models analyze nanomaterial
kinetics at the yolk sac–placenta, a structure com-
pletely different from the early human placenta
(Carney et al. 2004). The guinea pig model is com-
paratively advantageous because of a series of sim-
ilarities to human placentation (Grigsby 2016) and
has been used to study a NP-based vaccine in
pregnancy (Glenn et al. 2015), but early
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placentation in guinea pigs is also quite different
from humans.
However, studies have confirmed hypotheses on
parameters relevant for the uptake of nanomaterials
in cells and tissues, e.g. dose-, size-, and surface
charge-dependency (Oberdorster, Oberdorster, and
Oberdorster 2005; Maynard, Warheit, and Philbert
2011), in different placenta models (recently
reviewed by Keelan et al. 2015) and the limitations
of the approaches have been discussed (Correia
Carreira et al. 2015b; Keelan et al. 2015; Nikitina,
Dohr, and Juch 2015). For mouse placenta, a
charge- and dose-dependency of iron-oxide NP
accumulation in the fetus was confirmed (Di Bona
et al. 2014). In a recent study, targeted liposomes
were shown to deliver cargoes of carboxyfluorescein
and insulin-like growth factor 2 into the mouse pla-
centa, without interfering with fetal development;
human first trimester and term placental explants
showed a similar distribution of these liposomes
(King et al. 2016).
The variability of engineered nanomaterials
seems to be endless, promising possible solutions
for various diagnostic- and treatment-problems in
medicine, but also suggesting novel hazards.
Dendritic polyglycerol nanoparticles (dPG-NPs) are
of special interest, e.g. as drug carriers, since they
can be designed in a controlled manner to obtain a
defined size and functionalization (Calderon et al.
2010). Determined structure-biocompatibility rela-
tionships of dPG-NPs indicate their suitability for a
systemic administration (Khandare et al. 2010). The
dependency of cellular dPG-NP-uptake on surface
charge was described for epithelial cell lines and in
vivo experiments (Gr€oger et al. 2013; Pant et al.
2015).
To expand the knowledge in this field, we have
employed an established approach to investigate
the unique situation at the early human maternal-
embryonic interface, the human first- trimester
explant culture model (Miller et al. 2005). The
objective was to analyze time-, dose-, and charge-
dependency of dPG NP distribution at the early
human placental barrier. In addition, we studied the
impact of dPG-NP exposure on LDH release by
explants, BeWo cells, and primary trophoblasts, to
assess potential plasma membrane damage and the
impact on human chorionic gonadotropin (hCG) secre-
tion, to detect alterations of trophoblast physiology.
Moreover, the comparison of results of the different
models should improve our understanding of the
usability of easier to handle systems as a substitute
for placental explant culture.
Materials and methods
dPG-NP synthesis and characterization
All chemicals were reagent grade, used without fur-
ther purification, and purchased from Acros
Organics (Geel, Belgium), Sigma-Aldrich (Steinheim,
Germany), Fluka (Buchs, Switzerland), Merck KGaA
(Darmstadt, Germany), and Deutero (Kastellaun,
Germany). Reactions sensitive to moisture or air
were carried out under argon atmosphere using
anhydrous solvents and flame-dried glassware.
Dialysis was conducted in benzoylated cellulose
tubing purchased from Sigma-Aldrich (MWCO
2000 g mol1) changing the solvent at least four
times over a period of 48 h. Ultrafiltration was con-
ducted in solvent-resistant stirred cells (Millipore,
Merck KGaA) with PLAC regenerated cellulose mem-
branes (MWCO 1000 g mol1). SEC was performed
with SephadexTM G-25 superfine (Sigma Aldrich) in
distilled water under room temperature and pres-
sure. 1H- and 13C-NMR spectra were recorded on a
Jeol ECX 400 spectrometer (Jeol, Tokyo, Japan) or
on a Bruker Biospin Avance 700 spectrometer
(Bruker, Billerica, MA, USA). Chemical shifts (d) were
reported in ppm using the deuterated solvent peak
as the internal standard (D2O: d (
1H)¼ 4.79 ppm;
MeOD-d4: d (1H)¼ 3.31 ppm, d (13C)¼ 49.00 ppm;
CDCl3: d (
1H)¼ 7.26 ppm, d (13C)¼ 77.16 ppm). IR
measurements were recorded on a Nicolet Avatar
320 FT-IR equipped with a DTGS detector from 4000
to 650 cm1 and evaluated using the software EZ
OMNIC ESP. Wavenumbers tmax were reported in
cm1; intensities of the absorption bands were
assigned as strong (s), medium (m), and weak (w).
Elemental analysis to determine the degree of sulfa-
tion was performed on a VARIO EL III instrument
(Elementar, Hanau, Germany) using sulfanilic acid as
the standard. The average dye incorporation per
polymer was calculated by UV–Vis spectra from a
5 mM solution in PBS at pH 7.4 recorded on a
LAMBDA 950 UV/Vis/NIR spectrometer (PerkinElmer,
Waltham, MA, USA) at 25 C. DLS and f-potential
measurements were carried out on a Zetasizer Nano
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ZS (Malvern Instruments Ltd., Worcestershire, UK)
equipped with a 4mW He–Ne laser (k¼ 633 nm,
NIBS) operating with a 173 scattering angle (back-
scatter). Hydrodynamic diameters were determined
in UV-transparent disposable cuvettes (UltraVette,
8.5mm, Brand, Wertheim, Germany) at 25 C.
Samples were dissolved at a concentration of 2mg
mL1 in Dulbecco’s PBS (DPBS, without Ca2þ, Mg2þ,
pH =7.4, PAA, Pasching, Austria). The stated values
are the mean of at least 15 independent measure-
ments. f-potential measurements were conducted
at a concentration of 2mg mL1 in phosphate buf-
fer (PB, 10mM, pH 7.4) at 25 C in folded DTS 1060
capillary cells (Malvern Instruments Ltd.). Malvern
Zetasizer Software version 6.12 (Malvern
Instruments Ltd.) was used for data evaluation. The
stated values and standard deviations are based on
the Smoluchowski model and are the mean of at
least five independent measurements with 15 scans
each.
In order to monitor the charge dependent uptake
of nanoparticles by the human placenta, rhodamine
B (RB) conjugates of neutral, anionic, and cationic
dPG-NPs were synthesized, using a dPG scaffold
with a molecular weight of Mn = 6000 g mol1,
a polydispersity index (PDI) of 1.6, and a degree
of branching of 61%. Esterification of dPG with RB
using N-hydroxysuccinimide (NHS) and N,N0-dicyclo-
hexylcarbodiimide (DCC) according to a published
procedure (Gr€oger et al. 2014) gave neutral dPG-RB
(Figure 1, Supplementary Figure S1) with a dye to
polymer ratio of 0.06 (Table 1). The synthesis of
anionic RB labeled dPGS (dPGS-RB 5), later referred
to as ‘negatively charged dPG-NPs’, was accom-
plished by partial mesylation and azidation of the
neutral polymer, and subsequent sulfation of
remaining hydroxyl groups with SO3 pyridine com-
plex, followed by the copper-catalyzed click cou-
pling of alkyne functionalized RB to dPGS azide as
previously published (Figure 1, Supplementary
Figure S2, Gr€oger et al. 2014). The product was
obtained with a dye incorporation of 0.25 and a
degree of sulfation of 67% as determined by com-
bustion analysis (Table 1). Cationic dPGNH2-RB,
later referred to as ‘positively charged dPG-NPs’,
was prepared with 0.6 dyes per polymer (Table 1)
by mesylation, azidation, and reduction of residual
azide groups (Roller, Zhou, and Haag 2005) followed
by the conjugation of RB isothiocyanate to dPG
amine (6) (Figure 1, Supplementary Figure S2).
Figure 1. Schematic illustration of rhodamine B labeled dendritic polyglycerol (dPG-RB), dPG sulfate (dPGS-RB), and dPG amine
(dPGNH2-RB). Counter ions are not shown for clarity reasons.
Table 1. Characterization of rhodamine B labeled dPG nanoparticles.
Polymer Mn
a (g mol1) NFb dFc PDId dh ±SD
e (nm) f-potential ± SDf (mV) D/Pg
2 dPG-RB 6000 81 – 0.34 5.3 ± 0.7 0 0.06
5 dPGS-RB 12100 54 67 0.28 6.9 ± 1.1 27.9 ± 3.3 0.25
7 dPGNH2-RB 6000 73 90 0.37 5.6 ± 0.6 þ12.1 ± 1.6 0.6
aNumber average molecular weight calculated from the dF.
bNumber of functional groups per polymer.
cDegree of functionalization determined by 1H-NMR or elemental analysis.
dPolydispersity index (DLS).
eHydrodynamic diameter (mean ± standard deviation (SD)) by DLS in PBS (pH 7.4) from the size distribution by volume.
ff-potential (mean ± SD) in PBS (pH 7.4).
gDye to polymer ratio determined by UV–Vis spectroscopy at 25 C from a 5 mM solution in PBS.
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Derivatives were synthesized with hydrodynamic
diameters (Dh, volume distribution) between 5 and
7 nm as found by dynamic light scattering (DLS)
measurements in PBS (pH 7.4) and molecular
weights of 6 and 12.1 kDa as calculated from the
respective degree of functionalization (dF) (Table 1).
Surfaces charges were determined by f-potential
measurements in phosphate buffer (PB, pH 7.4) with
dPGNH2-RB showing a value of þ12mV, dPGS-RB of
28mV and dPG of 0mV, which are in accordance
to previously reported data of non-dye labeled com-
pounds (Weinhart, Becherer, and Haag 2011;
Weinhart et al. 2011; Mehrabadi et al. 2015).
NanoSightLM14 (Malvern Instruments Ltd.) was
used for nanoparticle tracking analysis (NTA) and
particle size determination in culture medium; laser
wavelength: 532 nm, filter for RB-fluorescence detec-
tion: 565 nm. Measurements were done at 25 C,
image capture: CMOS camera, 25 frames per
second, capture time 3 60 s, with and without fil-
ter. NTA version 3.2 Dev Build 3.2.16 software
(Malvern Instruments Ltd.) was used for data
analysis.
Cell and tissue culture
The study was approved by the ethic institutional
review board of the Medical University Graz (20-261
ex 08/09). First trimester placentas (n¼ 15, mean
gestational age¼ 8.5 ± 1.7) were obtained from
elective terminations of pregnancies (ETOP, not
Mifepristone-induced) and term placentas (n¼ 3)
were taken after cesarean section of non-compli-
cated pregnancies. BeWo cells were obtained from
ACC (Sigma-Aldrich). For experiments with first tri-
mester placental explants and BeWo cells DMEM/F-
12 (1:1), (GibcoVR , Life TechnologiesTM, Thermo Fisher
Scientific, Vienna, Austria) containing 10% fetal calf
serum (FCS, Life TechnologiesTM), 2mM Glutamin (L-
Glutamine 200mM (100X), GibcoVR ), and 1X antibioti-
c–antimycotic solution (Anti–Anti (100X), GibcoVR )
was used. For primary cytotrophoblast cell culture,
DMEM-HG (GibcoVR ) containing 10% FCS and 1X
antibiotic–antimycotic solution was applied. dPG-
NPs were diluted in complete culture medium to
concentrations of 1 mM and 10 nM. Cells and
explants were exposed to dPG-NPs for 6 and 24 h.
Placental explants from first trimester placentas
were prepared as described by Miller et al. (2005),
and incubated overnight in the ex vivo closed incu-
bation system (BioSpherix Ltd., Parish, NY, USA)
under hypoxic conditions (2.5% O2, 5% CO2) fol-
lowed by dPG-NP exposure in 96-well plates
(Thermo Fisher Scientific) for 6 h and in 24 well
plates for 24 h, on the bottom of the well, without
matrix-coating, one explant per well. Explants were
then fixed in 4% PFA (Merck KGaA) and embedded
in paraffin (Tissue-TekVR VIP, Sysmex, Vienna, Austria)
for subsequent histological processing.
BeWo cells were cultivated for 2 d on glass cov-
erslips in the six-well plates with a density of
2 105 cells per well (for microscopy) and in 96-
well plates with a density of 1 104 cells per well
(for toxicity tests) and afterwards exposed to dGP-
NPs at concentrations 1 mM and 10 nM.
According to the method described by Petroff
et al. (2006), primary trophoblast cells were isolated
from term placentas and seeded onto Collagen Typ
I coated, 4-well Culture Slides (BD Biosciences
GmbH, Vienna, Austria) with a density of 0.5 106
per chamber (for microscopy) and in 96-well plates
with a density of 1 105 per well (for toxicity tests)
for 2 d, followed by dPG-NP exposure at concentra-
tions of 1 mM and 10 nM.
Fluorescence and confocal microscopy
Placental explants of 5 mm sections were prepared
on adhesive glass slides (Superfrost PlusTM, Thermo
Fisher Scientific) deparaffinized, counterstained with
DAPI (VectashieldVR Mounting Medium for
Fluorescence with DAPI, Vector Laboratories, Szabo-
Scandic GmbH, Vienna, Austria) and analyzed, using
a fluorescence microscopy system Leica TCS SP2
(Leica Microsystems GmbH, Vienna, Austria)
equipped with a digital camera (AxioCam HRc, Carl
Zeiss GmbH, Vienna, Austria).
Biotinylated dPG-NPs were detected, using a
Streptavidin-Peroxidase-AEC detection system (Thermo
Fisher Scientific).
After exposure to dPG-NPs, BeWo cells from cover-
slips and primary trophoblast cells from chamber
slides were washed three times using HBSS (GibcoVR ),
fixed with 4% PFA for 20min and counterstained with
DAPI for evaluation on the confocal microscope.
Confocal microscopy was performed to distinguish
possible NP deposition on the outer cell surface from
intracellular dPG-NP deposits by choosing the optical
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sections at the estimated equatorial level of the
nuclei for analysis. Amira software version 3.1 (TGS
Template Graphics Software Inc., Bedford, UK) was
used for 3D reconstructions from Z-stacks.
Analysis of cytotoxicity and endocrine function
Supernatants from cells and placental explants were
frozen immediately at 80 C after centrifuging for
5min at 1000 rcf (HeraeusTM MegafugeTM 40R,
Thermo Fisher Scientific). Control measurements
were performed to exclude assay interaction with
FCS or nanoparticles. Unexposed cells and tissues
were used as negative controls, TritonVR X100 (Merck
KGaA; 1% vol. diluted in medium) exposure was
used to generate positive controls.
Lactate dehydrogenase (LDH) release was meas-
ured using a LDH Cytotoxicity Detection Kit (Takara
Bio Europe Inc., Saint-Germain-en-Laye, France), fol-
lowing the manufacturer’s instructions.
TUNEL assay
TUNEL technology, as described by the manufac-
turer (Roche Applied Science, Sigma-Aldrich), was
used to assess apoptosis. The trophoblast layers
were identified by E-Cadherin immunostaining,
using monoclonal anti-E-Cadherin (clone SPM471,
Thermo Fischer Scientific) and Alexa Fluor 633 goat
anti-mouse IgG (Molecular ProbesVR , Thermo Fisher
Scientific). Images were captured, using a Zeiss LSM
510 META Axiovert 200M Zeiss confocal system
(Carl Zeiss) with a 40 Plan-Neofluar 1.3 DIC oil
immersion objective. A mean of 1249 (range:
958–1755) trophoblast-nuclei was evaluated in ten
randomly selected areas for each treatment.
hCG measurement
The concentrations of hCG were determined in
diluted culture supernatants using the IMMULITE
2000 immunoassay system (Siemens Healthcare
Diagnostics GmbH, Vienna, Austria). dPG-NPs (1 mM)
were added to control samples after culture to
detect a potential direct interference of the dPG-
NPs with the assay.
Data analysis
All measurements were performed in duplicates,
quantitative data are displayed as mean values ±
standard error of mean (SEM) of three independent
placental explant culture experiments, three inde-
pendent primary trophoblast cultures, and three
independent BeWo cell cultures. ANOVA or
Kruskal–Wallis test was performed, using Graph pad
prism 7 (GraphPad Software, La Jolla, CA, USA) for
Windows, to evaluate the data and Bonferroni/Dunn’s
post hoc test was employed to analyze the statistical
significance of differences between exposures and
controls. p values<0.05 were considered significant.
Results
Localization of dPG-NP deposits in trophoblasts
and placental explants
Microscopy analysis revealed a charge-, exposure
time-, and dose-dependent dPG-NP accumulation in
both, trophoblasts and placental tissues (Figures 2
and 3). Deposits of negatively and positively
charged dPG-NPs were detectable in explants and
cells after 6 h of incubation, but no visible neutral
dPG-NP deposits appeared, even after 24 h of expos-
ure (Figure 2(A,B); Figure 3(C)). Biotin-labeled neutral
dPG-NPs were also undetectable in explants after
1 mM exposure for 24 h (Supplementary Figure 3).
Positively charged dPG-NPs (pos. dPG-NPs) showed
an increased cellular accumulation compared to
negatively charged dPG-NPs (neg. dPG-NPs) (Figure
2(C–F,G–L)); Figure 3(A,B)), but considering the dye
functionalization (D/P values in Table 1), this appar-
ent difference might be due to a better detectability
of pos. dPG-NPs. However, the comparatively more
intensive fluorescence signal in the syncytium in
Figure 3(D) indeed indicates a higher amount of neg.
dPG-NPs in the syncytium compared to pos. dPG-NPs
(Figure 3(E,F)), after 24h of exposure.
Neg. dPG-NP deposits remained clearly restricted
to the syncytium, even after 24 h of exposure
(Figure 3(D)). Notably, 24 h exposure to pos. dPG-
NPs resulted in deposits also in the cytotrophoblast
layer, at the basal membrane and even in cells of
the mesenchymal core (Figure 3(E,F)).
dPG-NP deposits in cells and tissues were not
evenly distributed, but did show a patchy accumula-
tion pattern with a preference of the perinuclear
area of cells (Figure 2(C–L); Figure 3(A,B,E,F);
Supplementary Figure S5). In areas of very intensive
dPG-NP accumulation, a more homogeneous
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staining of the cytoplasm occurred. As seen in the
confocal images, intra-nuclear deposits in tropho-
blast cells were rather an exception. Nuclear uptake
is difficult to assess in paraffin sections, since super-
position of perinuclear accumulations may appear
as intra-nuclear deposits, which cannot be ruled out
after 24 h of exposure (Figure 3(D–F)).
Interestingly, only BeWo cells showed cytoplasmic
and nuclear deposits of pos. dPG-NPs after 10 nM
exposure (Figure 2(K,L)), although the degree of
charged dPG-NP accumulation after 1 mM exposures
did not appear to be substantially higher in BeWo cells
(Figure 2(I,J)) compared to primary cytotrophoblasts
(Figure 2(G,H)) and explants (Figure 3(B,E,F)).
Toxicity and endocrine function
Evaluation of LDH release did not reveal dPG-NP
exposure to have any significant influence on LDH
activity in supernatants from cells and explants
(Figure 4 and Supplementary Figure S4), while
exposure to TritonVR X100 clearly increased LDH
Figure 2. Localization of differently charged (neutral (Neu; A,B), negative (Neg; C–F), positive (Pos; G–L)), labeled dPG-NPs (pink)
in exposed primary cytotrophoblasts (A–D,G,H), and BeWo cells (B,E,F,I–L). Exposure concentrations: 1 mM (A–J) and 10 nM (K,L)),
exposure time: 6 h (C,E,G,I,K), and 24 h (A,B,D,F,H,J,L). Nuclear staining: DAPI (blue). Confocal images, 400x. Patchy perinuclear and
nuclear localization was seen after 6 h of exposure to 1 mM neg. dPG-NPs (C,E) and pos. dPG-NPs (G,I), increasing after 24 h.
Notably, in BeWo cells pos. dPG-NP deposits were also detected after exposing them to a 10 nM concentration for 6 h (K) and 24 h
(L). No neutral dPG-NP deposits were detected in both cell types (A,B).
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release. dPG-NP exposure of BeWo and primary
trophoblast cells did not significantly change their
hCG release (with a tendency toward increase), how-
ever, 10 nM pos. dPG-NP and neg. dPG-NP exposure
for 24 h significantly decreased hCG release in pla-
cental explants, while no dPG-NPs deposits could be
detected. A similar, but insignificant trend was
observed after 6 h of incubation and for neutral
dPG-NPs after 24 h (Figure 4 and Supplementary
Figure S4). TUNEL analysis did not show significant
differences in trophoblast apoptosis rates after 24 h
compared to control (Supplementary Figure S6).
Adding dPG-NPs to supernatants from unexposed
control samples after culture did not alter the
results of hCG measurements (data not shown).
NTA in culture medium
Adding dPG-NPs (1 mM or less) to the culture
medium did not change the size distribution of
detectable particles. No formation of RB-fluorescent
agglomerates or aggregates above the detection
limit of 30–40 nm could be observed when using
the 565 nm filter (Supplementary Figure S7).
Figure 3. Localization of differently charged (neutral (Neu; C), negative (Neg; A,D), positive (Pos; B, E–F)), labeled dPG-NPs
(orange), in exposed placental explants. Exposure concentration: 1 mM, exposure-time: 6 h (A,B) and 24 h (C–F). Nuclear staining:
DAPI (blue). Fluorescence microscopy images, 200 (A,B), 1000 (C–F). Local staining of cytoplasm and nuclei in syncytiotropho-
blast (ST, arrows) was detected after 6 h of exposure to neg. and pos. dPG-NPs (A,B), increasing after 24 h. Notably, pos. dPG-NP
deposits, were localized at the basal membrane (thin arrows, F) close to the cytotrophoblast cell layer (CT) and in some cells of
mesenchymal core (short arrowheads) (E,F). No signal was observed for neu. dPG-NPs (C).
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Discussion
This is to our knowledge the first study describing
charge dependent soft matter NP interaction with
first-trimester human placenta in comparison to
BeWo and primary trophoblast cells.
Dose-, charge-, and time-dependent intracellular
accumulation of dPG-NPs are in agreement with
previous studies using highly similar particles in
non-trophoblast cells (Gr€oger et al. 2013), suggest-
ing a surface charge to be necessary for cellular
uptake. Neg. dPG-NPs show a distribution restricted
to the syncytiotrophoblast in early placenta, similar
to maternal immunoglobulin G (IgG) distribution in
early placenta (Bright, Ockleford, and Anwar 1994),
indicating possible similarities between the accumu-
lation processes of ‘natural’ NPs like IgG and neg.
dPG-NPs. Iron oxide NP studies in mice (Di Bona
et al. 2014) also revealed a charge dependency of
placental transfer in rodents. The affinity of posi-
tively charged particles to negatively charged loci of
the plasma membrane could be responsible for an
increased uptake into cells (Zhang et al. 2015).
However, the actual charge of NPs in the medium,
containing 10% FCS, considering an expectable
interaction with charged (e.g. protein) constituents of
the medium, remains to be elucidated. In this context,
the phenomenon of a protein-corona has been
repeatedly discussed (Nel et al. 2009). Notably, for
dPG-NPs of5 nm in diameter (about the size of albu-
min), a dPG-NP-mediated formation of a ‘protein
cloud’ in such complex biofluids should be expected,
including loosely attached, probably rapidly exchang-
ing layers of biomolecules (Docter et al. 2015).
While neg. dPG-NPs appear to accumulate
restricted to the syncytium, pos. dPG-NPs seem to
reach the mesenchymal core of the villi and might
therefore be less abundant in the syncytium after
24 h of exposure. This remarkable difference might
be caused by a preferable adherence of positively
charged NPs to transcytosis pathways in early pla-
centa, e.g. to flotillins (Walton et al. 2013).
The patchy distribution of NP accumulations
inside cells and the trophoblast layers suggests an
active transport of dPG-NPs into the cells and, at
least initially, a regulated intracellular deposition
rather than a passive diffusion. Membrane defects
allowing a passive diffusion of 5 nm particles
should have a substantial impact on viability,
comparable to perforins from cytotoxic T-cells, and
cause considerable necrosis and LDH release at least
after 24 h of persistence. An inhomogeneity of sur-
face exposure due to dPG-NP-related sedimentation
and agglomeration cannot be ruled out.
Nevertheless, the density of the dPG-NPs is lower
than the density of albumin in the medium, and the
low concentration of 1 nM (compared to 50 nM for
albumin) should also facilitate a homogeneous dis-
tribution, comparable to the distribution of the FCS-
proteins in the culture medium.
Indeed, an endocytosis-mediated uptake mechan-
ism has been suggested for macromolecules or
aggregates in general and NPs in particular
(Hillaireau and Couvreur 2009). Assuming an active
uptake, our data suggest a functional specialization
within the syncytium. The regionally restricted dPG-
NP accumulation, especially after 6 h, may be due
to a functional heterogeneity in terms of endocyto-
sis activity and particle deposition in first trimester
syncytium, which is generally considered to be
homogeneous, looking at organelle distribution, in
contrast to the syncytium in the second and third
trimester (Benirschke and Kaufmann 2012).
However, relatively little is known about the
intracellular fate and function of nanoparticles
(Deng and Gao 2016). Particularly noteworthy is
their possible impact on lysosomal function, which
is a key to using NPs as a delivery device, as well as
a potential cause of nanomaterial-mediated toxicity.
The proton sponge hypothesis posits that unsatur-
ated amines on the surface are capable of seques-
tering protons, thus keeping the pump of late
endosome going and thereby causing late endoso-
mal/lysosomal swelling and rupture, leading to par-
ticle release into the cytoplasm (Deng and Gao
2016). This mechanism could be employed by the
pos. dPG-NPs . It also remains to be elucidated in
which compartments or organelles the dPG-NP
accumulations exactly occur and to which extend
the particles are expelled by the trophoblast.
dPG-NPs tagged to be detectable in electron
microscopy could resolve such questions in fur-
ther studies.
Neither in trophoblasts nor in placental tissue
exposed to dPG-NPs did we find evidence for cell
membrane damage and LDH-release, compared to
controls. This is in line with previous observations,
showing no acute toxicity of dPG-NPs (Gr€oger et al.
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2013). Interestingly, we found a significant time-
dependent and a charge-dependent effect of dPG-
NPs (10 nM) on hCG secretion in placental explants.
The physiologic factors regulating hCG secretion in
vivo are still not fully understood. Much of what is
known about factors that stimulate (FGF, calcium,
glucocorticoids, phorbol esters, dynorphin and leptin)
or inhibit (TGF-b, follistatin and progesterone) hCG-
synthesis and secretion has been learned from
in vitro studies, which are difficult to extrapolate to
the in vivo situation (Barnea, Shurtz-Swirski, and
Kaplan 1992). There is strong evidence for
Figure 4. LDH- and hCG-levels in culture supernatants of placental explants, BeWo cells, and primary cytotrophoblast cells,
exposed to neutral (Neu), positively (Pos), and negatively charged (Neg) dPG-NPs for 24 h, at concentrations of 1 mM and 10 nM
and to 1% TritonVR X100. LDH data are shown in relative units as ratio to control values, while hCG data are presented in
mU mL1. (p< 0.05), (p< 0.01), and (p< 0.001) indicate statistically significant differences.
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cytotrophoblast and syncytiotrophoblast derived
Gonadotropin-releasing hormone (GnRH, identical to
hypothalamic GnRH), playing an important role in
hCG secretion, and GnRH antagonists have been
shown to decrease the basal hCG production. In
addition, hCG has been found to bind to the LH/
hCG receptor (LH/hCGR) and hCG mRNA expression
has been suggested to be autoregulated via LH/
hCGR, present on the trophoblast cells (Belisle et al.
1992). Placental hCG secretion is mediated by the
secretory granule-exocytosis pathway (Morrish,
Marusyk, and Siy 1987) and plays an important role
in gestation. Besides its endocrine function, hCG
acts via autocrine and paracrine pathways on cyto-
trophoblast differentiation, uterine angiogenesis,
placental immunology, uterine growth, quiescence
of uterine muscle contractions and even the growth
and development of fetal organs and the umbilical
cord (summarized by Cole 2010; Fournier,
Guibourdenche, and Evain-Brion 2015).
Based on the available data, two explanations for
our observations can be hypothesized: an uptake-
independent dPG-NP-interaction with the apical
membrane of the syncytium (1) via an undefined
specific receptor, causing interference with the
above-mentioned regulatory pathways or (2) by
unspecific blocking of exocytosis at the syncytiotro-
phoblast membrane.
Interestingly, the effect reached significance at
10 nM concentrations of dPG-NPs. This phenomenon
may be explained by dPG-NPs’ concentration-
dependent aggregation and agglomeration ten-
dency or a concentration-dependent binding to dif-
ferent biomolecules in the culture medium. If a
receptor-mediated effect is assumed, membrane
receptor desensitization or downregulation at
higher concentrations of dPG-NPs might be causa-
tive (Bourne and von Zastrow 2001).
Noteworthy, the effect only occurred in placental
explants but not in the other models. This pinpoints
the necessity of complex models, to understand
potential adverse effects of NPs at the feto-maternal
interface, and the mandatory wariness when using
only trophoblast cell lines, as a model of the placen-
tal barrier (Juch et al. 2013; Nikitina, Dohr, and Juch
2015). The presence of the original apical syncytial
membrane of early placenta, containing a unique
selection of specific membrane glycoproteins and
lipids, might be required for the observed response.
As previously suggested (Kao et al. 1988), Muoth
et al. also clearly demonstrated the high relevance
of the extracellular matrix for endocrine function
and hCG secretion of trophoblast cells, and showed
a NP-mediated reduction of hCG release in a 3D
BeWo/placental fibroblast co-culture micro tissue
model (Muoth et al. 2016).
In addition, we observed differences in the accu-
mulation of dPG-NPs between explants and the cell
culture models. Explants and primary cells did not
show a deposition of pos. dPG-NPs at a concentra-
tion of 10 nM, while BeWo cells did. This indicates
either a difference in the uptake mechanism or in
the excretion pathways between the choriocarcin-
oma cells and non-malignant trophoblast.
Strengths and limitations
An important strength of this study is the use of
human first-trimester explants cultures. Insight into
charge-dependent dPG-NP interaction with this very
specific barrier tissue is essential for understanding
possible influences of soft matter NP exposures in
pregnancy on human embryonic development. We
also used rather low (1 mM, 10 nM) dPG-NP concen-
trations to simulate a realistic exposure scenario;
dose recommendations for a common anti-TNFa
therapy (2.5–10mg/kg body weight) result in
plasma concentrations of the therapeutic protein-
NPs (monoclonal antibodies) in about this range.
Comparing this model to other placenta models
contributed to an understanding of important dif-
ferences in dPG-NP interaction, e.g. concerning the
dose-dependent accumulation of dPG-NPs within
different cells and tissues, or their influence on pla-
cental hormone secretion.
However, our study has some inevitable limita-
tions. First of all, the validity of the first-trimester
explant culture model for studying dPG-NP uptake
and dPG-NP-mediated effects in early human preg-
nancy has not been verified so far. Particularly the
dPG-NP surrounding in the culture medium is still
non-physiologic compared to the situation in utero, e.g.
in terms of protein composition and concentrations.
Especially the lack of clotting factors and mucin
components, which is expected to be relevant for
particle agglomeration and aggregation, but also
the absence of the intervillous space-specific pulsa-
tile flow, might have a significant impact on dPG-
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NP uptake (Juch et al. 2013). Additionally, in con-
trast to the term placenta perfusion model, where
intervillous space and fetal vessels are fully sepa-
rated by the placental barrier, arteries, and veins of
stem villi, opened at the cutting site, allow diffusion
of culture media components into the fetal vessels.
Therefore, NP deposits at the cutting site of the
explant and in the fetal vessels have to be inter-
preted with caution. For this reason, we focused our
analysis primarily on the distal parts of the explants
(immature intermediate villi and mesenchymal villi).
Furthermore, we could not locate dPG-NP- deposits
in any of the vessels in our explants after 24 h of
dPG-NP incubation.
Consequently, although working directly with tis-
sue representing the early human placental
barrier, deductions drawn from our results for the
in vivo-situation will remain hypothetical until future
accidental or inadvertent dPG-NP exposures in preg-
nancy will allow validation by analyzing maternal
hCG levels or particle distribution in early placenta
from spontaneous abortions or elective terminations
of pregnancy.
The limited sensitivity of the visualization sys-
tems, not allowing the detection of single 5 nm par-
ticles, precludes ruling out an uptake into cells and
tissues. Anyway, the detection of the dPG-NPs was
additionally limited by a biochemically restricted
D/P ratio <1 (Table 1). While the D/P ratios of nega-
tively- and positively charged dPG-NPs do not differ
substantially, the neutral dPG-NPs are clearly less
intensively labeled than the charged dPG-NPs. This
prevents us from being able to determine quantita-
tive differences in dPG-NP-uptake between charged
and uncharged dPG-NPs based on fluorescence
intensity and might explain why we could not
observe an uptake of neutral dPG-NPs in cells and
tissues. However, using neutral dPG-NPs labeled
with biotin instead of rhodamine, with a functionali-
zation of 2% corresponding to a biotin/particle
ratio of 1.6, and a highly sensitive streptavidin-
peroxidase based detection system, we could not
detect any neutral dPG-NP accumulation in explants
either (Supplementary Figure S3).
Purification of dPG-NPs after interaction with
diluted FCS was impossible and direct investigations
of at least the analytically accessible biomolecule-
and protein-attachments were not feasible.
Investigating a possible dPG-NP aggregation in
culture medium via NTA was technically limited to
aggregates of a hydrodynamic diameter >40 nm,
therefore, we cannot exclude a formation of smaller
dPG-NP aggregates in our culture medium.
In addition, dye leakage from the dPG-NPs due
to the cleavage of the ester bond cannot be fully
excluded. Under physiological conditions, however,
rhodamine dyes usually show a high stability (see
e.g. Gonc¸alves 2009). Of note, esters can be cleaved
under acidic conditions as well as upon treatment
with enzymes like esterase. We do not know to
which extend these phenomena occurred in our
physiologic culture media, but if there was a rhoda-
mine leakage causing significantly unspecific tissue
staining, we would rather expect a qualitatively
similar staining pattern for neutral, negative and
positive dPG-NP exposures.
One might speculate in this context that pro-
longed persistence of large amounts of dPG-NPs in
endosomes and lysosomes would lead to a release
of rhodamine, due to the acidic conditions and pos-
sibly catalyzed by lysosomal enzymes. Leakage of
free rhodamine from the lysosomes could lead to a
more homogeneous cytoplasmic and nuclear stain-
ing as observed in Figure 3(D).
The sensitivity of LDH-measurements for plasma
membrane damage in syncytiotrophoblast as a proxy
for compromised viability of the villi may be limited.
We cannot exclude that the observed significant
reduction in hCG secretion is a consequence of an
NP- mediated general impairment of trophoblast
metabolism or the disturbance of the unique cytotro-
phoblast-syncytiotrophoblast interaction (e.g. fusion)
occurring in explants. However, a TUNEL-test did not
indicate a significant influence of dPG-NP exposure
on the percentage of apoptotic trophoblast nuclei
after 24 h exposure, compared to control. An observ-
able trend toward an increase of TUNEL positive
nuclei in villi exposed to dPG-NPs at 10 nM might
indicate that a thorough investigation into the com-
plex apoptosis- phenomena, physiologically occur-
ring in placental trophoblast bilayers (Huppertz 2010)
would reveal significant effects, but this should be
investigated in detail in future studies.
Conclusion
Based on LDH measurements, dPG-NPs show charge-,
time-, and dose-dependent accumulation in early
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placental explants, BeWo cells and primary cytotro-
phoblast cells without acute toxic effects. A positive
charge seems to facilitate placental transfer into the
mesenchymal core of the villi, and thus potentially
into the fetal circulation. On the one hand, this might
be an important aspect for developing nano-based
therapeutics or diagnostics for the fetus. On the other
hand, this observation also contributes to teratologic
risk assessment of nanomaterial, where positive
charge would suggest a higher teratogenic potential.
Additionally, the observation of a charge-dependent
effect on secretion of hCG in placental explants, espe-
cially at very low concentrations, reminds us that we
also have to expect unpredictable effects of NPs in
vivo, e.g. a reduction of the hCG secretion. Our obser-
vation suggests that hCG levels in the first trimester
could be considered as an additional functional par-
ameter in studies on particle effects in pregnant
women, e.g. in context with air pollution (van den
Hooven et al. 2012).
Various adverse pregnancy outcomes, such as
pregnancy loss, intrauterine growth restriction, pre-
eclampsia or preterm birth, as well as a disturbance
of the maternal thyroid regulation in early gestation
(Korevaar et al. 2016) could possibly result from a
reduced hCG secretion and should be considered in
teratologic studies on particle exposure.
The fact that the latter phenomenon was found in
early placental explants, but not in simple trophoblast
monolayer cultures, pinpoints the importance of
choosing proper models for investigating NP effects
on the feto-maternal interface.
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